Hepatocellular Carcinoma
Full Form of HCB
What is HCB?
Hepatocellular carcinoma (HCC), commonly abbreviated as HCB in some clinical contexts, is the most prevalent form of primary liver cancer. It originates in hepatocytes, the main liver cells, and is strongly associated with chronic liver diseases such as hepatitis B and C infections, cirrhosis, and non-alcoholic fatty liver disease. In India, HCB is a major public health concern due to the high burden of viral hepatitis, particularly hepatitis B, which accounts for a significant proportion of liver cancer cases. The disease is often diagnosed at advanced stages because early symptoms are nonspecific, including abdominal pain, weight loss, and jaundice. Diagnosis typically involves imaging techniques like ultrasound, CT scan, or MRI, and is confirmed by biopsy or elevated alpha-fetoprotein (AFP) levels. HCB is a key topic in Indian medical entrance exams such as NEET PG and AIIMS, where questions on its etiology, staging, and treatment options frequently appear. Management depends on the stage and liver function, ranging from surgical resection and liver transplantation to locoregional therapies like radiofrequency ablation and transarterial chemoembolization, as well as systemic therapies including sorafenib. Awareness of HCB is crucial for healthcare professionals in India, given the rising incidence of liver disease and the need for early detection strategies. The term HCB is used in clinical notes, research papers, and textbooks to refer to this aggressive malignancy, emphasizing its significance in hepatology and oncology.
HCB का फुल फॉर्म
हेपेटोसेलुलर कार्सिनोमा
Example
The patient's liver ultrasound revealed a suspicious mass, and subsequent biopsy confirmed HCB, prompting immediate referral to the oncology department.